유비오맥파
BioSense
유비오맥파 is estimated to make < $5k per month from < 5k downloads / mo, tracked daily on Peekly.
How Peekly estimates these figures1) You must upgrade your existing uBioClip device to use it. 2) Can be installed and used on Android version 6.0 or higher. ※ Access permission information [Required access rights] -Storage space: Used by the
Overview
Estimated MRR
Downloads / mo
Top ads
Sign in to see this app's ad creatives
Rating & reviews
80 reviews
Performance metrics
Estimated MRR
Downloads / mo
Ranking · Top Free · Medical
16 Jul → 21 Aug · best #111
Ad reach
Ads
Ads launched per month
Rating & reviews
Review velocity
Advertising intelligence
Active ads
Media mix
Sign in to access this metricAds launched per month
Estimated spend:
Sign in to see the ad creatives and library
App details
About 유비오맥파
1) You must upgrade your existing uBioClip device to use it.
2) Can be installed and used on Android version 6.0 or higher.
※ Access permission information
[Required access rights]
-Storage space: Used by the user to save result files from the Ubio pulse wave device.
Rating & reviews
80 reviews
Monetization
Free
No in-app purchases detected
Similar apps
What's new
1.0.22 Android target SDK version update 1.0.23 Android 14 version update 1.0.24 Android 15 version update 1.0.25 Support for 16KB memory page size 1.0.27 Improved device connection convenience.
Frequently asked questions
How much does 유비오맥파 make?
유비오맥파 is estimated to make < $5k per month, according to Peekly's daily tracking.
How many downloads does 유비오맥파 have?
유비오맥파 has an estimated < 5k downloads / mo on Google Play.
Is 유비오맥파 free?
유비오맥파 is free to download.
What is 유비오맥파's rating?
유비오맥파 has a rating of 4.1 out of 5, based on 80 reviews.
Information
Publisher
BioSense
Category
Medical
Compatibility
6.0
Size
—
Rating
Rated for 3+
Price
Free
Released
—
Last update
Jun 29, 2026
Languages
—
Contact & links
Paywalls
Sign in to see captured paywall screens
Market context
Compare 유비오맥파 with the wider app market
Compare its revenue, downloads and momentum, then study the ads and paywalls competitors use to acquire and monetize users.